Program in Cancer Research Outcomes Training (PCORT)

描述（由申请人提供）：我们要求继续资助非常成功的丹娜-法伯/哈佛癌症中心（DF/HCC）癌症结局研究培训（PCRT）计划。PCOT是一个独特的，基于医学的，跨学科的计划，致力于培养癌症结果和医疗保健提供研究的领导者的目标，特别关注癌症预防和控制。我们相信，PCRT有足够的研究和培训机会，提供全面的研究培训经验，我们的成功-以及我们的学员的成功-证明这一要求继续资助。 资金将允许继续招聘2名新的医学博士。和/或博士培训生和1名新的博士前培训生每年。由于所有学员在该计划中至少花费2年时间，因此我们将始终保持该计划中的6名学员。我们将招募具有不同先前研究经验和培训的个人，并将所有学员融入高度协作的研究环境。我们还将积极招募高素质的少数民族和妇女申请人参加该计划。 该计划有3个组成部分：1）专业课程; 2）积极参与其他教学经验; 3）指导，多学科癌症相关成果研究。专业课程包括每周研讨会，包括教学讲座和“研究进展”的学员和教师介绍。合格的学员还参加哈佛临床有效性计划（PCE），这是布里格姆妇女医院、马萨诸塞州总医院、哈佛医学院和哈佛公共卫生学院的联合计划。PCE是一个密集的，为期七周，15学分的课堂计划，包括流行病学和生物统计学必修课程，以及各种选修课。我们鼓励学员报名参加或旁听整个哈佛大学系统中适合其培训水平的额外课程。虚拟医学博士博士后研究员完成硕士学位（M.P.H.）或M.Sc.）在哈佛公共卫生学院。 受训者花费大部分时间在PCOT导师的监督下参与指导的癌症结果研究。个人项目由受训者、他/她的导师和PCRT项目主任达成协议开发，并由PCRT咨询委员会批准。所有项目都是多学科和高度合作的。非常重视团队科学。学员接触到广泛的癌症结果研究方法和主题。 学员在整个过程中和完成课程后接受评估。在成功完成培训计划后，他们将做好充分准备，进行独立的，外部资助的癌症结果研究，并作为多学科研究团队的一部分有效地这样做。 公共卫生相关性：癌症结果研究的开展需要癌症护理专家以及技术评估和结果分析各方面的专家的参与，包括生物统计学，流行病学，经济学，决策科学和卫生政策，以确保研究得到适当的构思和执行，评估不仅正确评估干预措施的有效性，而且它们对癌症患者的管理以及对整个医疗保健系统的影响。我们已经成功地建立了一个计划（PCRT），跨越整个丹娜-法伯/哈佛癌症中心，并提供癌症结果研究的培训，桥梁传统的专科和学科为基础的培训经验。PCOT已经成功招募和培训了一批优秀的未来领导者，他们将在癌症结果研究方面发挥重要作用;持续的资金将使我们能够在其他支持这些人的资源不足的时候继续这样做。 变得更加难以获得。

DESCRIPTION (provided by applicant): We request continued funding for the highly successful, Dana-Farber/Harvard Cancer Center (DF/HCC) Program in Cancer Outcomes Research Training (PCORT). PCORT is a unique, curriculum-based, inter-disciplinary program dedicated to the goal of training leaders in cancer outcomes and healthcare delivery research, with a particular focus on cancer prevention and control. We believe that PCORT has sufficient research and training opportunities to provide a comprehensive research training experience, and that our success - and the success of our trainees - justifies this request for continued funding. Funding will allow continued recruitment of 2 new M.D. and/or Ph.D. trainees and 1 new pre-doctoral trainee per year. Because all trainees spend a minimum of 2 years in the Program, we will maintain a total of 6 trainees in the Program at all times. We will recruit individuals wit diverse prior research experience and training, and will integrate all trainees into a highly collaborative research environment. We will also actively recruit highly qualified minority and women applicants to the program. The Program has 3 components: 1) a specialized curriculum; 2) active participation in other didactic experiences; and, 3) mentored, multidisciplinary cancer-related outcomes research. The specialized curriculum involves weekly seminars, including both didactic lectures and "research-in-progress" presentations by trainees and faculty. Appropriately qualified trainees also attend the Harvard Program in Clinical Effectiveness (PCE), a joint Program of Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, and Harvard School of Public Health. The PCE is an intensive, seven-week, 15 credit classroom-based program that includes required courses in epidemiology and biostatistics, as well as a variety of electives. Trainees are encouraged to enroll in or may audit additional courses throughout the Harvard University system that are appropriate for their level of training. Virtuall all M.D. post-doctoral fellows complete a Masters Degree (M.P.H. or M.Sc.) at the Harvard School of Public Health. Trainees spend the largest part of their time participating in mentored cancer outcomes research under the supervision of PCORT mentors. Individual projects are developed by agreement among the trainee, his/her mentors and the PCORT Program Director, and approved by the PCORT Advisory Committee. All projects are multidisciplinary and highly collaborative. There is a strong emphasis on team science. Trainees are exposed to a broad range of cancer outcomes research methods and topics. Trainees are evaluated throughout and upon completion of the Program. After successful completion of the training program, they will be well prepared to conduct independent, externally funded, cancer outcomes research, and to do so effectively as part of a multidisciplinary research team. PUBLIC HEALTH RELEVANCE: The conduct of cancer outcomes research requires the participation of experts in cancer care, as well as experts in all aspects of technology assessment and outcomes analysis, including biostatistics, epidemiology, economics, decision science, and health policy, to ensure that studies are properly conceived and executed, and that evaluations properly assess not only the efficacy of interventions, but also their impact on the management of patients with cancer, and on the healthcare system overall. We have successfully established a program (PCORT) that spans the entire Dana-Farber/Harvard Cancer Center and provides training in cancer outcomes research that bridges traditional subspecialty- and discipline-based training experiences. PCORT has successfully recruited and trained an outstanding group of future leaders in cancer outcomes research; continued funding will allow us to continue to do so at a time when other sources of support for these individuals is becoming more difficult to obtain.